Rob Steendam is Co-Founder and Chief Technology Officer at InnoCore. He has over 20 years of experience related to the development of biomaterials and biomedical, drug delivery, and combination products with previous experience at companies like AkzoNobel and Polyganics (now Regenity). He is an inventor of several patents and co-author of multiple peer-reviewed articles related to biodegradable multi-block copolymers and their application in parenteral drug delivery and drug eluting implants. He holds an MSc in polymer chemistry and a PhD in Pharmaceutical Technology, both from the University of Groningen, the Netherlands.